Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.69 |
| ▸ | CCR3 | P51677 | 1/20 | 0.67 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.63 |
| ▸ | HTR2A | P28223 | 3/20 | 0.62 |
| ▸ | HTR2C | P28335 | 2/20 | 0.62 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.62 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.62 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.61 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.60 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.58 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.57 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.57 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.57 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.57 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10458165 | 0.89 | SLC6A3 (0.70) | ACHECCR3SLC6A3HTR2AHTR2C | |
| SCHEMBL7983946 | 0.89 | SIGMAR1 (0.70) | CCR3HTR2ASPHK1CYP1A2CYP3A4 | |
| SCHEMBL5537485 | 0.89 | ACHE (0.60) | ACHECCR3SLC6A3HTR2AHTR2C | |
| SCHEMBL5534146 | 0.89 | ACHE (0.60) | ACHECCR3SLC6A3HTR2AHTR2C | |
| SCHEMBL6423692 | 0.89 | ACHE (0.60) | ACHECCR3SLC6A3HTR2AHTR2C | |
| SCHEMBL10438853 | 0.88 | SIGMAR1 (0.69) | CCR3SPHK1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL3958257 | 0.84 | HRH3 (0.58) | ACHECCR3CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL14100275 | 0.84 | SPHK1 (0.65) | ACHECCR3HTR2AHTR2CSPHK1 | |
| SCHEMBL4255182 | 0.83 | ACHE (0.71) | ACHECCR3SLC6A3HTR2AHTR2C | |
| SCHEMBL24495209 | 0.82 | SPHK1 (0.63) | ACHECCR3HTR2AHTR2CSPHK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0385044-A1 | New piperidine derivatives as antihistaminics | FABRICA ESPANOLA DE PRODUCTOS QUIMICOS Y FARMACEUTICOS, S.A. (FAES) (ES) | 1990-09-05 | — | — | EP | claimed |
| EP-3597670-B1 | WATER-SOLUBLE COMPOSITION, PRODUCTION METHOD FOR CURED PRODUCT THEREOF, AND CURED PRODUCT THEREOF, AND ACYL PHOSPHINATE | ADEKA CORP (JP) | 2024-07-10 | — | — | EP | disclosed |
| US-20230349869-A1 | METHODS AND SYSTEMS FOR OPIOID DETECTION | NAT TECH & ENG SOLUTIONS SANDIA LLC (US) | 2023-11-02 | — | — | US | disclosed |
| US-11733217-B1 | Methods and systems for opioid detection | NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC (US) | 2023-08-22 | — | — | US | disclosed |
| US-11649334-B2 | Water-soluble composition, production method for cured product thereof, and cured product thereof, and acyl phosphinate | ADEKA CORPORATION (JP) | 2023-05-16 | — | — | US | disclosed |
| WO-2021106678-A1 | ACYLPHOSPHINE COMPOSITION, POLYMERIZATION INITIATOR, POLYMERIZABLE COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT | 株式会社ADEKA | 2021-06-03 | — | — | WO | disclosed |
| WO-2021095711-A1 | POLYMERIZABLE COMPOSITION, VEHICLE, AND CURED OBJECT AND PRODUCTION METHOD THEREFOR | 株式会社ADEKA | 2021-05-20 | — | — | WO | disclosed |
| US-20210107887-A1 | RADICAL POLYMERIZATION INITIATOR, COMPOSITION CONTAINING SAME, CURED PRODUCT OF COMPOSITION, PRODUCTION METHOD FOR CURED PRODUCT, AND COMPOUND | ADEKA CORPORATION (JP) | 2021-04-15 | — | — | US | disclosed |
| EP-3753958-A1 | RADICAL POLYMERIZATION INITIATOR, COMPOSITION CONTAINING SAME, CURED PRODUCT OF COMPOSITION, PRODUCTION METHOD FOR CURED PRODUCT, AND COMPOUND | ADEKA CORPORATION (JP) | 2020-12-23 | — | — | EP | disclosed |
| US-20200032021-A1 | WATER-SOLUBLE COMPOSITION, PRODUCTION METHOD FOR CURED PRODUCT THEREOF, AND CURED PRODUCT THEREOF, AND ACYL PHOSPHINATE | ADEKA CORPORATION (JP) | 2020-01-30 | — | — | US | disclosed |
| EP-0063365-B2 | 1,4-Dihydropyridine derivative and pharmaceutical composition containing same | KYOWA HAKKO KOGYO KK (JP) | 1994-06-15 | — | — | EP | disclosed |
| EP-0149088-B1 | PYRIDINE-2-ETHERS RESPECTIVELY PYRIDINE-2-THIOETHERS WITH A NITROGEN CONTAINING CYCLOALIPHATIC RING AND SULFOXIDES,SULFANES AND PYRIDIN-N-OXIDES THEREOF | ASTA Pharma Aktiengesellschaft (DE) | 1989-01-18 | — | — | EP | disclosed |
| US-4643995-A | Analgesic pyridine-2-ethers or pyridine-2-thioethers having a nitrogen-containing cycloaliphatic ring | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1987-02-17 | — | — | US | disclosed |
| EP-0079740-B1 | ANTHRANILOYLOXYALKANOATES | RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY (CH) | 1985-11-13 | — | — | EP | disclosed |
| EP-0063365-B1 | 1,4-DIHYDROPYRIDINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1985-09-04 | — | — | EP | disclosed |
| EP-0149088-A1 | Pyridine-2-ethers respectively pyridine-2-thioethers with a nitrogen containing cycloaliphatic ring and sulfoxides,sulfanes and pyridin-N-oxides thereof | ASTA Pharma Aktiengesellschaft (DE) | 1985-07-24 | — | — | EP | disclosed |
| US-4482561-A | ANALGESICS, ANTIINFLAMMATORY AGENT, ANTICOAGULANT, AND ANTIDEPRESSANT | RECORDATI, S. A., CHEMICAL & PHARMACEUTICAL CO. (CH) | 1984-11-13 | — | — | US | disclosed |
| US-4448964-A | HYPOTENSIVE AGENTS; VASODILATORS | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1984-05-15 | — | — | US | disclosed |
| EP-0079740-A1 | Anthraniloyloxyalkanoates | RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY (CH) | 1983-05-25 | — | — | EP | disclosed |
| EP-0063365-A1 | 1,4-Dihydropyridine derivative and pharmaceutical composition containing same | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1982-10-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200032021-A1 | WATER-SOLUBLE COMPOSITION, PRODUCTION METHOD FOR CURED PRODUCT THEREOF, AND CURED PRODUCT THEREOF, AND ACYL PHOSPHINATE | PHOSPHO1, ASS1, SGMS1 | ACHE 1346/4885CCR3 4836/4885SLC6A3 4697/4885 |
| US-11649334-B2 | Water-soluble composition, production method for cured product thereof, and cured product thereof, and acyl phosphinate | PHOSPHO1, ASS1, SGMS1 | ACHE 1346/4885CCR3 4836/4885SLC6A3 4697/4885 |
| US-20210107887-A1 | RADICAL POLYMERIZATION INITIATOR, COMPOSITION CONTAINING SAME, CURED PRODUCT OF COMPOSITION, PRODUCTION METHOD FOR CURED PRODUCT, AND COMPOUND | RRP12, ASH2L, RER1 | ACHE 3014/4885CCR3 3055/4885SLC6A3 4819/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.